IMVT
ImmunovantCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
IMVT vs peer average
57/100
IMVT vs. peer average (C vs. C)
Grade spread
B 1 · C 3 · D 5
Graded peers loaded
Coverage
9 graded
100% of tracked
Peer overview
CELC is the first available peer comparator.
Closest size-and-stage comp: a mid-cap clinical biotech where valuation is primarily driven by program data readouts, safety, and trial execution rather than current earnings power.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
IMVT
Immunovant
CELC
Celcuity
Grade
C
D
Momentum
90
18
Value
41
41
Sentiment
35
73
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs CELC
IMVT / CELC
Grade Position
In line
IMVT vs. peer average (C vs. C)
57/100
Momentum
90
IMVTValue
41
IMVTSentiment
35
CELCRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs IMVT
CELC is the first peer returned for this comparison set.